Understanding how certain brain cells help repair spinal cord injuries
Functional Diversity of Reactive Astrocytes in Spinal Cord Repair
['FUNDING_R01'] · UNIVERSITY OF KENTUCKY · NIH-11061926
This study is looking at how certain brain cells help heal spinal cord injuries, focusing on how they create scars and support new nerve growth, with the hope of finding better treatments for patients like you.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KENTUCKY (nih funded) |
| Locations | 1 site (LEXINGTON, UNITED STATES) |
| Trial ID | NIH-11061926 on ClinicalTrials.gov |
What this research studies
This research investigates the role of reactive astrocytes, a type of brain cell, in the healing process after spinal cord injuries. It aims to identify how different types of these cells contribute to both the formation of scars at the injury site and the growth of new nerve fibers in surrounding areas. By studying the molecular and cellular mechanisms involved, the research seeks to uncover how to effectively harness these cells for better recovery outcomes. Patients may benefit from insights that could lead to new treatments for spinal cord injuries.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced spinal cord injuries and are seeking potential new treatment options.
Not a fit: Patients with spinal cord injuries that are too chronic or have progressed beyond the point of potential recovery may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies that enhance recovery from spinal cord injuries.
How similar studies have performed: Previous research has shown promise in targeting reactive astrocytes for neural repair, indicating that this approach may lead to significant advancements in treatment.
Where this research is happening
LEXINGTON, UNITED STATES
- UNIVERSITY OF KENTUCKY — LEXINGTON, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: CHEN, MEIFAN — UNIVERSITY OF KENTUCKY
- Study coordinator: CHEN, MEIFAN
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.